Test Module 2

We acknowledge the urgency of catalysing a step-change in political support and financing for the ACT- Accelerator in order to enable it to deliver on its mission of accelerating the discovery and deployment of new COVID-19 tools to all people, everywhere.

Roles: Everyone: All Users

Regions: Norway , South Africa

Topics: Coronavirus (COVID-19), Global Health

Today Dr Tedros Adhanom Ghebreyesus, WHO Director-General, and Dr Ursula von der Leyen, President of the European Commission, co-hosted the inaugural meeting of the Access to COVID-19 Tools (ACT) Accelerator Facilitation Council.

Roles: Everyone: All Users

Regions: Canada , China, France , Italy , Norway , Rwanda , South Africa , United Kingdom , Uzbekistan

Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health

This letter will focus largely on WHO’s efforts to address the double challenge of malaria & COVID-19. Our work in recent months has been carried out in close collaboration with country-based experts and global partners. We are very grateful to all of our partners for their ongoing commitment and contributions.

Roles: Everyone: All Users

Regions: Chad , China, France , Italy , Rwanda , Sierra Leone , United Kingdom

Topics: Coronavirus (COVID-19), Global Health

Togo has received validation from the World Health Organization (WHO) for having eliminated human African trypanosomiasis or “sleeping sickness” as a public health problem, becoming the first country in Africa to reach this milestone.

Roles: Everyone: All Users

Regions: Ghana , Togo , United Kingdom

Topics: Global Health

Joint release by the World Health Organization, United for Global Mental Health and the World Federation for Mental Health

Mental health is one of the most neglected areas of public health. Close to 1 billion people are living with a mental disorder, 3 million people die every year from the harmful use of alcohol and one person dies every 40 seconds by suicide. And now, billions of people around the world have been affected by the COVID-19 pandemic, which is having a furth

Roles: Everyone: All Users

Regions: Argentina, Peru , United Kingdom , United States

Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Global Health, Human Rights and Democracy, Refugee and Humanitarian Assistance

• Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
  
• 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

  Roles: Everyone: All Users

  Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

  Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• INFOSAN Quarterly Summary, 2020 #2

  During the second quarter of 2020, the INFOSAN Secretariat has been involved in 29 food safety incidents with 59 WHO Member States and two territories of WHO Member States. There were 13 biological hazard incidents (Salmonella [5], Listeria monocytogenes [3], Clostridium botulinum [2], Vibrio cholerae [1], and two involving an unspecified biological hazard), six with a chemical hazard (methanol [3], histamine [2] and patulin [1]), five involving an undeclared allergen (cashew and pistachio [1], sesame [1],

  Roles: Everyone: All Users

  Regions: Australia , Cambodia , Canada , China, Dominican Republic , France , Hong Kong , Mexico , Singapore , United States

  Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Energy, Global Health

• #EndTB Webinar: From Policy to Practice: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment

  A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.

  Roles: Everyone: All Users

  Regions: United Kingdom

  Topics: Global Health, Science, Technology, and Innovation

• Public statement for collaboration on COVID-19 vaccine development

  Roles: Everyone: All Users

  Regions: Argentina, Canada , Chad , China, Norway , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

• A meeting on digital innovations, TB and implementation research organised by WHO and the European Respiratory Society

  Roles: Everyone: All Users

  Regions: Tanzania , Ukraine , United Kingdom

  Topics: Global Health, Science, Technology, and Innovation

• WHO and partners call for urgent investment in nurses

  Roles: Everyone: All Users

  Regions: United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Global Women's Issues, Science, Technology, and Innovation